🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, double masked, randomized, multi-center, parallel-group,...
Status
Completed
Location
United Medical Research Institute
Start Date
2020-06-06
Trial ID
NCT04405245
Treatments Being Tested
Objective: To evaluate the safety and efficacy of topical cyclosporine eye...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00824811
People who have hayfever or allergic rhinitis often complain about eye symp...
Status
Completed
Location
The University of Chicago
Start Date
2009-11
Trial ID
NCT01007253
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of short rag...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-20
Trial ID
NCT02478398
A randomized, multicenter, double masked, placebo controlled, parallel grou...
Status
Completed
Location
Key-Whitman Eye Center
Start Date
2018-03-28
Trial ID
NCT03499873
Treatments Being Tested
To investigate the efficacy and safety of FK506 ophthalmic suspension on ey...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00567762
This study evaluates the use of Brimonidine tartrate nanoemulsion eye drop ...
Status
Terminated
Location
Mayo Clinic
Start Date
2018-12-23
Trial ID
NCT03591874
Treatments Being Tested
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Phase 3 Evalu...
Status
Completed
Location
Eye Hospital, Wenzhou Medical University
Start Date
2023-09-27
Trial ID
NCT06045299
Cornea transplant recipients who are using topical corticosteroids long-ter...
Status
Completed
Location
Price Vision Group
Start Date
2017-09-05
Trial ID
NCT03248037
Treatments Being Tested
The primary purpose of this study is to assess efficacy and safety of Latis...
Status
Completed
Location
Kenneth R. Beer, M.D. ,PA
Start Date
2011-03
Trial ID
NCT01387906
Treatments Being Tested